1. Home
  2. SMTI vs RCEL Comparison

SMTI vs RCEL Comparison

Compare SMTI & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sanara MedTech Inc.

SMTI

Sanara MedTech Inc.

HOLD

Current Price

$24.55

Market Cap

208.2M

Sector

Health Care

ML Signal

HOLD

Logo Avita Medical Inc.

RCEL

Avita Medical Inc.

HOLD

Current Price

$5.04

Market Cap

126.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SMTI
RCEL
Founded
1982
N/A
Country
United States
United States
Employees
N/A
226
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
208.2M
126.8M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
SMTI
RCEL
Price
$24.55
$5.04
Analyst Decision
Strong Buy
Buy
Analyst Count
2
5
Target Price
$34.00
$7.88
AVG Volume (30 Days)
57.3K
346.8K
Earning Date
05-12-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.05
N/A
Revenue
$15,586,976.00
N/A
Revenue This Year
$17.31
$17.17
Revenue Next Year
$12.48
$49.82
P/E Ratio
$496.80
N/A
Revenue Growth
32.47
N/A
52 Week Low
$16.05
$3.22
52 Week High
$35.70
$7.12

Technical Indicators

Market Signals
Indicator
SMTI
RCEL
Relative Strength Index (RSI) 62.65 71.78
Support Level $20.47 $5.03
Resistance Level $26.48 $5.13
Average True Range (ATR) 1.38 0.29
MACD 0.21 0.11
Stochastic Oscillator 97.59 97.08

Price Performance

Historical Comparison
SMTI
RCEL

About SMTI Sanara MedTech Inc.

Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.

About RCEL Avita Medical Inc.

Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: